Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $16.00 at Truist Financial

Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its price objective boosted by Truist Financial from $12.00 to $16.00 in a report issued on Friday, Benzinga reports. Truist Financial currently has a buy rating on the stock. TMCI has been the topic of several other reports. Stifel Nicolaus cut their target price on shares of […]

Related Keywords

United States ,Stifel Nicolaus ,Morgan Stanley ,Tower Research Capital ,Treace Medical Concepts Inc ,Altshuler Shaham Ltd ,Treace Medical Concepts ,Free Report ,Truist Financial ,Moderate Buy ,Medical Concepts ,Get Free Report ,Treace Medical ,Shaham Ltd ,Research Capital ,Treace Medical Concepts Daily ,Nasdaq Tmci ,Tmci ,Medical ,Boost Price Target ,Truist Financial Co ,